Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " February 20, 2008":" March 21, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" February 20, 2008":" March 21, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (32 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
Condition: HIV Infections
Interventions: Drug: Maraviroc (UK-427,857);   Other: Placebo
2 Completed Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: HIV immune globulin solution
3 Completed
Has Results
Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid
Condition: HIV Infections
Intervention:
4 Completed Experimental Design of Couple Counseling and Testing in Antenatal Clinics in Dar es Salaam, Tanzania
Condition: HIV Infections
Interventions: Behavioral: Couples VCT;   Behavioral: Individual VCT
5 Completed Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial
Condition: HIV Infections
Interventions: Drug: EFV+TDF;   Drug: EFV+3TC+TDF
6 Completed An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects
Condition: HIV Infections
Intervention: Drug: Emtricitabine
7 Unknown  Impact of Antiretroviral Therapy on Cardiac Biomarkers
Condition: HIV Infections
Intervention:
8 Completed
Has Results
Raltegravir Intensification in HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Placebo
9 Completed HIV Prevention With the Mentally Ill
Condition: HIV Infections
Interventions: Behavioral: Skills Building with Motivational Interviewing;   Behavioral: Skills Building
10 Completed Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens
Condition: HIV Infections
Interventions: Drug: LPV/r;   Drug: LPV/r + TDF/FTC or TDF/3TC
11 Completed
Has Results
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
Conditions: HIV -1 Infection;   HIV Infections
Interventions: Drug: PRO 140 (humanized monoclonal antibody to CCR5);   Drug: Placebo Comparator
12 Completed Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
13 Completed Lopinavir/Ritonavir Monotherapy in Children
Condition: HIV Infections
Intervention: Drug: LPV/r
14 Completed Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
Conditions: HIV Infections;   HIV Positive;   Pregnant Women
Intervention:
15 Completed HORIZONS HIV Intervention
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: HORIZONS HIV Intervention;   Behavioral: enhanced standard-of-care
16 Terminated Reactogenicity and Immunogenicity of Vaginal CNgp140
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Biological: HIV glycoprotein CN54gp140 (vaccine);   Biological: Carbopol 974
17 Completed Effects Of Food And Dose Regimen On The Antiviral Effects Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus
Condition: HIV
Interventions: Drug: Maraviroc (UK-427,857);   Other: Placebo
18 Completed
Has Results
Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin
Conditions: HIV Infections;   Hyperlipidemia
Interventions: Drug: Pravastatin;   Drug: Darunavir;   Drug: Ritonavir;   Other: Washout
19 Completed Effectiveness of an Abstinence-Only HIV/Sexually Transmitted Disease Risk-Reduction Intervention for Young African-American Adolescents
Conditions: HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: Abstinence-only HIV/STD risk-reduction intervention;   Behavioral: Safer-sex-only HIV/STD risk-reduction intervention;   Behavioral: Long comprehensive HIV/STD risk-reduction intervention;   Behavioral: Short comprehensive HIV/STD risk-reduction intervention;   Behavioral: Health promotion control intervention
20 Active, not recruiting Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
Conditions: HIV Infections;   Staphylococcal Infections
Interventions: Drug: Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.